Skip to main content
    M

    Molina Healthcare Inc (MOH)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $233.25
    +23.76 (+11.34%)

    Market Cap: $10.89B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Molina Healthcare Inc (MOH) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Molina Healthcare (MOH) trades at 116.6x trailing earnings and 0.3x sales. Its P/E of 116.6x is above its 5-year median of 16.5x. Its forward P/E is 21.4x. The median P/E across 12 similar companies is 17.4x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 444.9% higher over the next year. Its free cash flow yield is 1.9%.

    MultipleValue
    P/E (trailing)116.6x
    Forward P/E21.4x
    Price to sales0.3x
    Price to book2.9x
    EV/EBITDA34.4x
    Price to FCF51.6x
    EV/FCF48.6x
    PEG1.1
    FCF yield1.9%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 638.0% above 15.8x, its P/S is 40.0% below 0.5x and its P/B is 38.3% below 4.7x.

    MultipleCurrent5-year median10-year median
    P/E116.6x16.5x15.8x
    P/S0.3x0.5x0.5x
    P/B2.9x4.3x4.7x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 105 to 120 months (10-year).

    Valuation History

    Over the 9 of the 10 year ends shown that have a P/E, its P/E ranged from 11.1x in 2018 to 110.7x in 2016.

    Year endPriceP/EP/SP/B
    2025$173.5416.3x0.2x2.2x
    2024$291.0512.8x0.4x3.7x
    2023$361.3117.3x0.6x5.0x
    2022$330.2218.4x0.6x6.5x
    2021$318.0823.5x0.7x7.1x
    2020$212.6814.7x0.6x6.0x
    2019$135.6911.6x0.5x4.4x
    2018$116.2211.1x0.4x4.7x
    2017$76.68N/A0.2x3.4x
    2016$54.26110.7x0.2x1.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MOH

    What is MOH's forward P/E ratio?

    Molina Healthcare has a forward P/E ratio of 21.4x.

    Is MOH stock overvalued?

    GNG's valuation label for MOH is Undervalued. Its P/E of 116.6x compares with a median of 17.4x across 12 similar companies.

    What is MOH's price to sales ratio?

    Molina Healthcare has a price to sales ratio of 0.3x.

    What is Molina Healthcare's average P/E ratio over 5 years?

    Molina Healthcare's median P/E over the last 5 years is 16.5x, from 60 month-end values through Oct 2026.

    What is MOH's PEG ratio?

    Molina Healthcare has a PEG ratio of 1.1.